Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole in Restless Legs Syndrome
NCT00363857Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2003
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in restless legs syndrome (RLS) comparing Ropinirole with Placebo (2 arms). Primary endpoint: International Restless Legs Scale Score at 12 weeks. Started Aug 2003; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00363857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363857.